IL1B and gout: Given that monosodium urate crystals drive gouty inflammation primarily through NLRP3 inflammasome activation and the subsequent release of IL-1β and IL-18 [32], the suppressive effects of GDF15 on these mediators suggest a potential regulatory role in modulating gout-associated inflammatory responses.